nodes	percent_of_prediction	percent_of_DWPC	metapath
Tasosartan—CYP3A4—Cytochrome P450 - arranged by substrate type—FDX1—pancreatitis	0.00282	0.00283	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CX3CL1—pancreatitis	0.00281	0.00282	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CCK—pancreatitis	0.00273	0.00274	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—MTNR1B—pancreatitis	0.00273	0.00274	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CNR2—pancreatitis	0.00266	0.00267	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—TACR1—pancreatitis	0.00266	0.00267	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—MTNR1B—pancreatitis	0.00266	0.00267	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CCKAR—pancreatitis	0.00262	0.00263	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—CCL2—pancreatitis	0.00261	0.00262	CbGpPWpGaD
Tasosartan—AGTR2—G alpha (i) signalling events—CXCL8—pancreatitis	0.00259	0.0026	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CNR2—pancreatitis	0.00259	0.0026	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—SST—pancreatitis	0.00257	0.00258	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCKAR—pancreatitis	0.00255	0.00256	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—HTR2A—pancreatitis	0.00254	0.00255	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—PTHLH—pancreatitis	0.00249	0.0025	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—BDKRB2—pancreatitis	0.00245	0.00246	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PNLIP—pancreatitis	0.00244	0.00245	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—BDKRB2—pancreatitis	0.00242	0.00243	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—PPY—pancreatitis	0.00235	0.00236	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CX3CL1—pancreatitis	0.00234	0.00235	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—GCG—pancreatitis	0.00232	0.00233	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—FDX1—pancreatitis	0.00228	0.00229	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—SST—pancreatitis	0.00228	0.00229	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCK—pancreatitis	0.00228	0.00228	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—pancreatitis	0.00228	0.00228	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PTHLH—pancreatitis	0.00226	0.00227	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—SMO—pancreatitis	0.00226	0.00227	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—KNG1—pancreatitis	0.00223	0.00224	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—TACR1—pancreatitis	0.00222	0.00223	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CNR2—pancreatitis	0.00222	0.00223	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—KNG1—pancreatitis	0.0022	0.00221	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—BDKRB2—pancreatitis	0.00219	0.0022	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PPY—pancreatitis	0.00219	0.00219	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatitis	0.00218	0.00219	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PPP3CA—pancreatitis	0.00216	0.00216	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—BDKRB2—pancreatitis	0.00214	0.00215	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—pancreatitis	0.00212	0.00213	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—CNR1—pancreatitis	0.0021	0.00211	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—pancreatitis	0.00208	0.00208	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—SST—pancreatitis	0.00207	0.00208	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatitis	0.00206	0.00207	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—GCG—pancreatitis	0.00203	0.00204	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—pancreatitis	0.00203	0.00204	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—CXCL8—pancreatitis	0.00202	0.00203	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—pancreatitis	0.00199	0.002	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—CCL2—pancreatitis	0.00199	0.00199	CbGpPWpGaD
Tasosartan—Valsartan—ALB—pancreatitis	0.00197	0.672	CrCbGaD
Tasosartan—AGTR2—GPCR downstream signaling—KNG1—pancreatitis	0.00195	0.00195	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—BDKRB2—pancreatitis	0.00195	0.00195	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IL1B—pancreatitis	0.00194	0.00195	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—CASP3—pancreatitis	0.00194	0.00194	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CNR1—pancreatitis	0.00191	0.00192	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—BDKRB2—pancreatitis	0.00189	0.0019	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CNR1—pancreatitis	0.00186	0.00186	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—GCG—pancreatitis	0.00184	0.00185	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CCL5—pancreatitis	0.00184	0.00185	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—SCT—pancreatitis	0.00182	0.00182	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CASR—pancreatitis	0.00182	0.00182	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CX3CL1—pancreatitis	0.00178	0.00179	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—KNG1—pancreatitis	0.00177	0.00178	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CCK—pancreatitis	0.00173	0.00174	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—MTNR1B—pancreatitis	0.00173	0.00174	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—SST—pancreatitis	0.00173	0.00173	CbGpPWpGaD
Tasosartan—CYP3A4—Tryptophan metabolism—ALDH2—pancreatitis	0.0017	0.00171	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SCT—pancreatitis	0.00169	0.0017	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—FGG—pancreatitis	0.00169	0.0017	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CASR—pancreatitis	0.00169	0.0017	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CNR2—pancreatitis	0.00169	0.00169	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—TACR1—pancreatitis	0.00169	0.00169	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CCKAR—pancreatitis	0.00166	0.00167	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CX3CL1—pancreatitis	0.00166	0.00166	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—HTR2A—pancreatitis	0.00164	0.00165	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—CCL5—pancreatitis	0.00163	0.00163	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—pancreatitis	0.00162	0.00163	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCK—pancreatitis	0.00161	0.00162	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MTNR1B—pancreatitis	0.00161	0.00162	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatitis	0.00159	0.0016	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pancreatitis	0.00158	0.00159	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—A2M—pancreatitis	0.00157	0.00158	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CNR2—pancreatitis	0.00157	0.00158	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TACR1—pancreatitis	0.00157	0.00158	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—CXCL8—pancreatitis	0.00157	0.00158	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCKAR—pancreatitis	0.00155	0.00155	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—TGFB1—pancreatitis	0.00151	0.00151	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CCL5—pancreatitis	0.00148	0.00148	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—KNG1—pancreatitis	0.00148	0.00148	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—pancreatitis	0.00147	0.00147	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—FGA—pancreatitis	0.00144	0.00144	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—HTR2A—pancreatitis	0.00144	0.00144	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—SMO—pancreatitis	0.00144	0.00144	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—PTHLH—pancreatitis	0.00144	0.00144	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—TNF—pancreatitis	0.00141	0.00141	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PTHLH—pancreatitis	0.00134	0.00134	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SMO—pancreatitis	0.00134	0.00134	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PPY—pancreatitis	0.00133	0.00133	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—SST—pancreatitis	0.00131	0.00132	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—FGB—pancreatitis	0.00131	0.00131	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—HTR2A—pancreatitis	0.0013	0.00131	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PPP3CA—pancreatitis	0.00128	0.00128	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—pancreatitis	0.00127	0.00127	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CCL2—pancreatitis	0.00127	0.00127	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—BDKRB2—pancreatitis	0.00124	0.00124	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—pancreatitis	0.00123	0.00124	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SST—pancreatitis	0.00122	0.00123	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—FDX1—pancreatitis	0.00121	0.00122	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CNR1—pancreatitis	0.00121	0.00122	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—DUSP6—pancreatitis	0.00121	0.00122	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PPY—pancreatitis	0.00121	0.00121	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—GCG—pancreatitis	0.00117	0.00117	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—BDKRB2—pancreatitis	0.00115	0.00115	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CNR1—pancreatitis	0.00113	0.00113	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—ADH4—pancreatitis	0.00113	0.00113	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—KNG1—pancreatitis	0.00112	0.00113	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—pancreatitis	0.00112	0.00112	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—GCG—pancreatitis	0.00109	0.00109	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—pancreatitis	0.00109	0.00109	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—KNG1—pancreatitis	0.00105	0.00105	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—SCT—pancreatitis	0.00103	0.00103	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CASR—pancreatitis	0.00103	0.00103	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CCL2—pancreatitis	0.00102	0.00102	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CXCL8—pancreatitis	0.001	0.00101	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CCK—pancreatitis	0.00098	0.000983	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—MTNR1B—pancreatitis	0.00098	0.000983	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PDGFA—pancreatitis	0.000962	0.000964	CbGpPWpGaD
Tasosartan—Losartan—ALB—pancreatitis	0.000961	0.328	CrCbGaD
Tasosartan—AGTR1—GPCR downstream signaling—TACR1—pancreatitis	0.000955	0.000958	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CNR2—pancreatitis	0.000955	0.000958	CbGpPWpGaD
Tasosartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatitis	0.000941	0.000944	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CCL5—pancreatitis	0.00094	0.000943	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CCKAR—pancreatitis	0.000939	0.000942	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—SCT—pancreatitis	0.000933	0.000935	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CASR—pancreatitis	0.000933	0.000935	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CX3CL1—pancreatitis	0.000915	0.000917	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—MTNR1B—pancreatitis	0.00089	0.000892	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCK—pancreatitis	0.00089	0.000892	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—CXCL8—pancreatitis	0.000888	0.00089	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCL5—pancreatitis	0.000874	0.000877	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CNR2—pancreatitis	0.000867	0.00087	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—TACR1—pancreatitis	0.000867	0.00087	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—LPL—pancreatitis	0.000855	0.000858	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCKAR—pancreatitis	0.000853	0.000856	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—pancreatitis	0.00085	0.000853	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—ADH1B—pancreatitis	0.000841	0.000843	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—HTR2A—pancreatitis	0.000829	0.000831	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PTHLH—pancreatitis	0.000812	0.000814	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SPP1—pancreatitis	0.00081	0.000812	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CXCL8—pancreatitis	0.000806	0.000809	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PNLIP—pancreatitis	0.000795	0.000797	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HTR2A—pancreatitis	0.000771	0.000773	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—SST—pancreatitis	0.000743	0.000745	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—SMO—pancreatitis	0.000737	0.000739	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PTHLH—pancreatitis	0.000737	0.000739	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatitis	0.000728	0.00073	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—LEP—pancreatitis	0.000717	0.000719	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PPY—pancreatitis	0.000713	0.000715	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PPP3CA—pancreatitis	0.000703	0.000705	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—BDKRB2—pancreatitis	0.000698	0.0007	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CNR1—pancreatitis	0.000685	0.000687	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—SST—pancreatitis	0.000674	0.000676	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatitis	0.000672	0.000674	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GCG—pancreatitis	0.000662	0.000664	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CCL2—pancreatitis	0.000647	0.000649	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—NRAS—pancreatitis	0.000647	0.000649	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—KNG1—pancreatitis	0.000635	0.000637	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—BDKRB2—pancreatitis	0.000634	0.000636	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatitis	0.000627	0.000629	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CNR1—pancreatitis	0.000622	0.000624	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—INS—pancreatitis	0.000612	0.000614	CbGpPWpGaD
Tasosartan—CYP3A4—Tryptophan metabolism—MDM2—pancreatitis	0.000603	0.000605	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCL2—pancreatitis	0.000602	0.000604	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GCG—pancreatitis	0.000601	0.000603	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—ALDH2—pancreatitis	0.000592	0.000594	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—KNG1—pancreatitis	0.000577	0.000578	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—KRAS—pancreatitis	0.000557	0.000558	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CASR—pancreatitis	0.000551	0.000553	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SCT—pancreatitis	0.000551	0.000553	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FGG—pancreatitis	0.000551	0.000553	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CX3CL1—pancreatitis	0.00054	0.000542	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatitis	0.000533	0.000534	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CCL5—pancreatitis	0.000531	0.000533	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCK—pancreatitis	0.000526	0.000527	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MTNR1B—pancreatitis	0.000526	0.000527	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—A2M—pancreatitis	0.000512	0.000514	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CNR2—pancreatitis	0.000512	0.000514	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TACR1—pancreatitis	0.000512	0.000514	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CXCL8—pancreatitis	0.000512	0.000513	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—pancreatitis	0.00051	0.000511	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MDM2—pancreatitis	0.000509	0.000511	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCKAR—pancreatitis	0.000504	0.000505	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCL5—pancreatitis	0.000482	0.000484	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CXCL8—pancreatitis	0.000476	0.000478	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—HRAS—pancreatitis	0.000473	0.000475	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FGA—pancreatitis	0.000468	0.00047	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—HTR2A—pancreatitis	0.000468	0.00047	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CASP3—pancreatitis	0.000456	0.000457	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL6—pancreatitis	0.000453	0.000454	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTHLH—pancreatitis	0.000436	0.000437	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SMO—pancreatitis	0.000436	0.000437	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FGB—pancreatitis	0.000426	0.000427	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HTR2A—pancreatitis	0.000425	0.000426	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PPP3CA—pancreatitis	0.000415	0.000417	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SST—pancreatitis	0.000398	0.000399	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—DUSP6—pancreatitis	0.000395	0.000396	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NRAS—pancreatitis	0.000382	0.000383	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—BDKRB2—pancreatitis	0.000375	0.000376	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CNR1—pancreatitis	0.000368	0.000369	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GCG—pancreatitis	0.000355	0.000356	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TGFB1—pancreatitis	0.000355	0.000356	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KNG1—pancreatitis	0.000341	0.000342	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCL2—pancreatitis	0.000332	0.000333	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—KRAS—pancreatitis	0.000329	0.00033	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PDGFA—pancreatitis	0.000313	0.000314	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CXCL8—pancreatitis	0.000289	0.00029	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCL5—pancreatitis	0.000285	0.000286	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HRAS—pancreatitis	0.00028	0.00028	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—LPL—pancreatitis	0.000279	0.000279	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL6—pancreatitis	0.000268	0.000268	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SPP1—pancreatitis	0.000264	0.000265	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CXCL8—pancreatitis	0.000263	0.000263	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HTR2A—pancreatitis	0.000251	0.000252	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CTRB2—pancreatitis	0.000239	0.00024	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—LEP—pancreatitis	0.000234	0.000234	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—NRAS—pancreatitis	0.000211	0.000211	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—FDX1—pancreatitis	0.000207	0.000208	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—INS—pancreatitis	0.000199	0.0002	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCL2—pancreatitis	0.000196	0.000197	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ADH4—pancreatitis	0.000193	0.000193	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—KRAS—pancreatitis	0.000181	0.000182	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PRSS1—pancreatitis	0.000181	0.000182	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PRSS3—pancreatitis	0.000172	0.000172	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PNLIP—pancreatitis	0.000172	0.000172	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MDM2—pancreatitis	0.000166	0.000166	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCL8—pancreatitis	0.000155	0.000156	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HRAS—pancreatitis	0.000154	0.000155	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—XDH—pancreatitis	0.000154	0.000155	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CASP3—pancreatitis	0.000149	0.000149	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL6—pancreatitis	0.000148	0.000148	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ADH1B—pancreatitis	0.000144	0.000144	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NRAS—pancreatitis	0.000124	0.000125	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TGFB1—pancreatitis	0.000116	0.000116	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PLA2G1B—pancreatitis	0.000115	0.000115	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—A2M—pancreatitis	0.000111	0.000111	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KRAS—pancreatitis	0.000107	0.000107	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALDH2—pancreatitis	0.000101	0.000102	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HRAS—pancreatitis	9.11e-05	9.13e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL6—pancreatitis	8.72e-05	8.74e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GCG—pancreatitis	7.68e-05	7.7e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—LPL—pancreatitis	6.02e-05	6.04e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPARG—pancreatitis	4.4e-05	4.41e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—INS—pancreatitis	4.31e-05	4.33e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALB—pancreatitis	3.96e-05	3.97e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTGS2—pancreatitis	3.46e-05	3.47e-05	CbGpPWpGaD
